id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-2826-0002,FDA,FDA-2022-N-2826,"Allergan Sales LLC., et. al.; Withdrawal of Approval of 10 Abbreviated New Drug Applications; Correction",Notice,Correction,2023-02-02T05:00:00Z,2023,2,2023-02-02T05:00:00Z,,2023-02-02T14:46:05Z,2023-02155,0,0,090000648562c22f